We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
-4.5%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$508M
AUM Growth
+$83.8M
Cap. Flow
+$371M
Cap. Flow %
73%
Top 10 Hldgs %
48.66%
Holding
368
New
95
Increased
39
Reduced
35
Closed
113

Top Buys

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$25.5M
2
MSTR icon
Strategy Inc
MSTR
+$22.3M
3
IMCR icon
Immunocore
IMCR
+$13M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$11.2M
5
BABA icon
Alibaba
BABA
+$9.93M

Sector Composition

Rank Sector Weight
1 Technology 24.85%
2 Financials 17.41%
3 Communication Services 10.98%
4 Consumer Discretionary 8.69%
5 Healthcare 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JSPR icon
176
PUT
Jasper Therapeutics
JSPR
$22.9M
$70.5K 0.01%
10,000
-3,600
-26% -$86.3K
PLBY icon
177
Playboy Inc
PLBY
$141M
$63.7K 0.01%
82,008
LU icon
178
Lufax Holding
LU
$1.2B
$60.6K 0.01%
+25,578
New +$97.5K
HUM icon
179
CALL
Humana
HUM
$46.7B
$53.1K 0.01%
+5,000
New +$1.69M
ECX icon
180
ECARX Holdings
ECX
$393M
$51.5K 0.01%
+25,000
New +$37.9K
RENEW
181
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$50.5K 0.01%
2,397,500
SKYX icon
182
SKYX Platforms
SKYX
$155M
$50.4K 0.01%
53,010
JSPR icon
183
CALL
Jasper Therapeutics
JSPR
$22.9M
$48.2K 0.01%
+13,600
New +$326K
BMEA icon
184
Biomea Fusion
BMEA
$90.4M
$45K 0.01%
10,000
-11,000
-52% -$112K
JBIO
185
PUT
Jade Biosciences
JBIO
$1.22B
$40.1K 0.01%
+106
New +$70.3K
AMZN icon
186
CALL
Amazon
AMZN
$2.5T
$38.1K 0.01%
+40,000
New +$7.35M
IRAAW
187
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$35K 0.01%
875,817
TE
188
T1 Energy
TE
$1.4B
$34K 0.01%
20,000
LCID icon
189
Lucid Motors
LCID
$2.46B
$31.7K 0.01%
1,214
-30
-2% -$801
SQNS
190
Sequans Communications SA
SQNS
$37.4M
$31.2K 0.01%
2,480
XELA
191
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$31K 0.01%
12,774
RLMD icon
192
Relmada Therapeutics
RLMD
$544M
$30K 0.01%
10,000
-63,500
-86% -$230K
ABPWW
193
DELISTED
Abpro Holdings Warrant
ABPWW
$30K 0.01%
375,000
SDSTW
194
Stardust Power Inc Warrant
SDSTW
$4.56M
$28.5K 0.01%
158,540
THCPW
195
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$28.3K 0.01%
166,700
MDAI icon
196
Spectral AI
MDAI
$52.2M
$26.8K 0.01%
15,246
RNLX
197
DELISTED
Renalytix plc American Depositary Shares
RNLX
$26.6K 0.01%
+115,000
New +$68.5K
SKGRW
198
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$26.5K 0.01%
111,832
-30,100
-21% -$9.25K
QVCGA
199
DELISTED
QVC Group Inc Series A
QVCGA
$25.3K 0.01%
802
-400
-33% -$16.6K
HYAC.WS
200
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
$24.2K ﹤0.01%
138,250

Similar funds

Cantor Fitzgerald's Q2 2024 Portfolio in Review

As of Q2 2024, Cantor Fitzgerald held 368 positions worth $508M, up 20% from $424M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Cantor Fitzgerald deployed $371M of net new capital in Q2 2024, opening 95 new positions and adding to 39 existing holdings. Its largest new stake was Super Micro Computer: 298,270 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 14% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was ProShares UltraPro QQQ, an estimated $20.1M trimmed.

  • Cantor Fitzgerald's largest Q2 2024 buy was Super Micro Computer: 298,270 shares worth $24.4M.
  • Cantor Fitzgerald added most to Strategy Inc in Q2 2024, an estimated $22.3M increase.
  • Cantor Fitzgerald's biggest Q2 2024 reduction was ProShares UltraPro QQQ, cutting an estimated $20.1M.
  • Cantor Fitzgerald fully exited Inhibrx, Inc. Common Stock in Q2 2024, selling an estimated $4.88M.
  • Cantor Fitzgerald's ten largest holdings make up 49% of its $508M portfolio in Q2 2024.
  • Cantor Fitzgerald opened 95 new positions and closed 113 in Q2 2024.
  • Cantor Fitzgerald's portfolio value rose 20% quarter-over-quarter to $508M.

Based on Cantor Fitzgerald's 13F filing for Q2 2024, filed 14 Aug 2024.